TrialNCT07402876Phase 3Recruiting
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
Study sponsor: Aldeyra Therapeutics, Inc. · ALDX
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2026-12Estimated
Enrollment · participants20Estimated
Source updated2026-02-11Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.